Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance.

Caratelli S, Sconocchia T, Arriga R, Coppola A, Lanzilli G, Lauro D, Venditti A, Del Principe MI, Buccisano F, Maurillo L, Ferrone S, Sconocchia G.

Front Immunol. 2017 Apr 27;8:457. doi: 10.3389/fimmu.2017.00457. eCollection 2017. Review.

2.

The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators.

Capuani B, Pacifici F, Pastore D, Palmirotta R, Donadel G, Arriga R, Bellia A, Di Daniele N, Rogliani P, Abete P, Sbraccia P, Guadagni F, Lauro D, Della-Morte D.

Pharmacol Res. 2016 Sep;111:659-667. doi: 10.1016/j.phrs.2016.07.029. Epub 2016 Jul 25. Review.

PMID:
27461137
3.

T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cells.

D'Aloia MM, Caratelli S, Palumbo C, Battella S, Arriga R, Lauro D, Palmieri G, Sconocchia G, Alimandi M.

Cytotherapy. 2016 Feb;18(2):278-90. doi: 10.1016/j.jcyt.2015.10.014. Epub 2015 Dec 17.

PMID:
26705740
4.

Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage.

Arriga R, Caratelli S, Coppola A, Spagnoli GC, Venditti A, Amadori S, Lanzilli G, Lauro D, Palomba P, Sconocchia T, Del Principe MI, Maurillo L, Buccisano F, Capuani B, Ferrone S, Sconocchia G.

Oncotarget. 2016 Jan 12;7(2):2070-9. doi: 10.18632/oncotarget.6529.

5.

SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α.

Pastore D, Della-Morte D, Coppola A, Capuani B, Lombardo MF, Pacifici F, Ferrelli F, Arriga R, Mammi C, Federici M, Bellia A, Di Daniele N, Tesauro M, Donadel G, Noto D, Sbraccia P, Sconocchia G, Lauro D.

Cell Death Dis. 2015 Sep 17;6:e1890. doi: 10.1038/cddis.2015.232.

6.

Serum- and Glucocorticoid-Inducible Kinase 1 Delay the Onset of Endothelial Senescence by Directly Interacting with Human Telomerase Reverse Transcriptase.

Basello K, Pacifici F, Capuani B, Pastore D, Lombardo MF, Ferrelli F, Coppola A, Donadel G, Arriga R, Sconocchia G, Bellia A, Rogliani P, Federici M, Sbraccia P, Lauro D, Della-Morte D.

Rejuvenation Res. 2016 Feb;19(1):79-89. doi: 10.1089/rej.2015.1726.

PMID:
26230157
7.

NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma.

Coppola A, Arriga R, Lauro D, Del Principe MI, Buccisano F, Maurillo L, Palomba P, Venditti A, Sconocchia G.

Front Med (Lausanne). 2015 May 26;2:33. doi: 10.3389/fmed.2015.00033. eCollection 2015. Review.

8.

Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients.

Benvenuto M, Sileri P, Rossi P, Masuelli L, Fantini M, Nanni M, Franceschilli L, Sconocchia G, Lanzilli G, Arriga R, Faggioni G, Lista F, Orlandi A, Manzari V, Gaspari AL, Modesti A, Bei R.

J Transl Med. 2015 Mar 28;13:101. doi: 10.1186/s12967-015-0455-7.

9.

Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology.

Capuani B, Della-Morte D, Donadel G, Caratelli S, Bova L, Pastore D, De Canio M, D'Aguanno S, Coppola A, Pacifici F, Arriga R, Bellia A, Ferrelli F, Tesauro M, Federici M, Neri A, Bernardini S, Sbraccia P, Di Daniele N, Sconocchia G, Orlandi A, Urbani A, Lauro D.

Am J Physiol Endocrinol Metab. 2015 May 1;308(9):E744-55. doi: 10.1152/ajpendo.00447.2014. Epub 2015 Feb 24.

10.

NK cells and T cells cooperate during the clinical course of colorectal cancer.

Sconocchia G, Eppenberger S, Spagnoli GC, Tornillo L, Droeser R, Caratelli S, Ferrelli F, Coppola A, Arriga R, Lauro D, Iezzi G, Terracciano L, Ferrone S.

Oncoimmunology. 2014 Aug 3;3(8):e952197. eCollection 2014.

11.

HLA-DRB1*13:01 allele in the genetic susceptibility to colorectal carcinoma.

Aureli A, Canossi A, Del Beato T, Franceschilli L, Buonomo O, Papola F, De Sanctis F, Lanzilli G, Sileri P, Coppola A, Caratelli S, Arriga R, Orlandi A, Lauro D, Rossi P, Sconocchia G.

Int J Cancer. 2015 May 15;136(10):2464-8. doi: 10.1002/ijc.29285. Epub 2014 Oct 30.

12.

Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia.

Ferrelli F, Pastore D, Capuani B, Lombardo MF, Blot-Chabaud M, Coppola A, Basello K, Galli A, Donadel G, Romano M, Caratelli S, Pacifici F, Arriga R, Di Daniele N, Sbraccia P, Sconocchia G, Bellia A, Tesauro M, Federici M, Della-Morte D, Lauro D.

Acta Diabetol. 2015 Feb;52(1):55-64. doi: 10.1007/s00592-014-0600-4. Epub 2014 Jun 25.

PMID:
24961472
13.

Peroxiredoxin 6, a novel player in the pathogenesis of diabetes.

Pacifici F, Arriga R, Sorice GP, Capuani B, Scioli MG, Pastore D, Donadel G, Bellia A, Caratelli S, Coppola A, Ferrelli F, Federici M, Sconocchia G, Tesauro M, Sbraccia P, Della-Morte D, Giaccari A, Orlandi A, Lauro D.

Diabetes. 2014 Oct;63(10):3210-20. doi: 10.2337/db14-0144. Epub 2014 Jun 19.

14.

HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Sconocchia G, Eppenberger-Castori S, Zlobec I, Karamitopoulou E, Arriga R, Coppola A, Caratelli S, Spagnoli GC, Lauro D, Lugli A, Han J, Iezzi G, Ferrone C, Ferlosio A, Tornillo L, Droeser R, Rossi P, Attanasio A, Ferrone S, Terracciano L.

Neoplasia. 2014 Jan;16(1):31-42.

15.

Melanoma cells inhibit NK cell functions.

Sconocchia G, Arriga R, Tornillo L, Terracciano L, Ferrone S, Spagnoli GC.

Cancer Res. 2012 Oct 15;72(20):5428-9; author reply 5430. doi: 10.1158/0008-5472.CAN-12-1181. Epub 2012 Oct 9. No abstract available.

Supplemental Content

Loading ...
Support Center